Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Cell type, Lymphoma, Non-Hodgkin lymphoma (NHL)
Closed
Phase 2
This study is comparing 2 treatments, ibrutinib and rituximab with chemotherapy and rituximab. It is for people aged 60 or older with mantle cell lymphoma. And it is for people who have not had any treatment.
Mantle cell lymphoma is a rare type of non Hodgkin lymphoma (NHL). This study is supported by Cancer Research UK.
Recruitment start: 22 December 2015
Recruitment end: 30 June 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Simon Rule
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Haematological Malignancies Diagnostic Service (HMDS)
Janssen Pharmaceutical Companies
NIHR Clinical Research Network: Cancer
Peninsula Clinical Trials Unit, Plymouth University
University Hospitals Plymouth NHS Trust
This is Cancer Research UK trial number CRUK/14/026
Last reviewed: 18 September 2024
CRUK internal database number: 12656
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
